Nevro Corp. stock is up 20.1% since 30 days ago. The next earnings date is Feb 15, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 9 November’s closed higher than October. In the last 4 Unusual Options Trades, there were 4 PUTs. 0% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
13 Oct 17:55 | 21 Jun, 2024 | 25.00 | 50 | ||
13 Oct 17:55 | 21 Jun, 2024 | 22.50 | 0 | ||
13 Oct 17:55 | 21 Jun, 2024 | 22.50 | 0 | ||
24 Oct 16:10 | 17 Nov, 2023 | 20.00 | 150 |
Nevro Corp. provides products for patients suffering from chronic pain in the United States and internationally. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro was incorporated in 2006 and is headquartered in Redwood City, California.